Abstract

Two studies highlight the risks associated with widely used sympathomimetic drugs.The first, a case-control study, was designed to assess the

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call